Furthermore, HLA-DR expression (both frequency and MFI) significantly increased in RA patients after treatment with TNF-inhibitors and tocilizumab, when comparing baseline and follow-ups (Fig 7). This evidence concerns the gene TNF and rheumatoid arthritis.